Sphera Funds Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Sphera Funds Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-165,295	Closed	-$2.38M	–	170
2021 Q2	$2.38M	Sell	165,295 -1,037	-0.6%	-$5.2K	0.16%	102
2021 Q1	$702K	Hold	166,332	–	–	0.05%	154
2020 Q4	$940K	Buy	+166,332	New	+$671K	0.08%	100

Sphera Funds Management's CEREW Position: Q3 2021 in Review

Sphera Funds Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 165,295 shares — an estimated $2.38M sold.

Sphera Funds Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $2.38M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Sphera Funds Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Sphera Funds Management sold 165,295 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $2.38M.
Sphera Funds Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Sphera Funds Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $2.38M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.